KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Dividends Paid - Common (2016 - 2025)

Historic Dividends Paid - Common for Eli Lilly (LLY) over the last 17 years, with Q4 2025 value amounting to $1.3 billion.

  • Eli Lilly's Dividends Paid - Common rose 1520.68% to $1.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $5.4 billion, marking a year-over-year increase of 1504.27%. This contributed to the annual value of $5.4 billion for FY2025, which is 1504.27% up from last year.
  • As of Q4 2025, Eli Lilly's Dividends Paid - Common stood at $1.3 billion, which was up 1520.68% from $1.3 billion recorded in Q3 2025.
  • In the past 5 years, Eli Lilly's Dividends Paid - Common ranged from a high of $1.3 billion in Q2 2025 and a low of $768.3 million during Q2 2021
  • In the last 5 years, Eli Lilly's Dividends Paid - Common had a median value of $1.0 billion in 2023 and averaged $1.0 billion.
  • Examining YoY changes over the last 5 years, Eli Lilly's Dividends Paid - Common showed a top increase of 1541.79% in 2021 and a maximum decrease of 1395.73% in 2021.
  • Over the past 5 years, Eli Lilly's Dividends Paid - Common (Quarter) stood at $773.3 million in 2021, then rose by 14.37% to $884.4 million in 2022, then grew by 15.08% to $1.0 billion in 2023, then rose by 14.75% to $1.2 billion in 2024, then grew by 15.21% to $1.3 billion in 2025.
  • Its Dividends Paid - Common stands at $1.3 billion for Q4 2025, versus $1.3 billion for Q3 2025 and $1.3 billion for Q2 2025.